In 89 breast cancer lesions found during clinical breast cancer screening with combined usage of mammography (MMG) and Ultrasonography (US) between February 1995 and August 2002, we found 20 cases were negative for MMG and 13 were negative for US detection. In this study we reexamined those cases of breast cancer undetectable either by MMG or breast US. The 11 of the 20 MMG negative cases, lesions were still undetectable by secondary extended examination using MMG, however, we found 9 lesions were positive for MMG by refined technique of delineation. In the 12 US negative lesions, a secondary extended examination performed using US showed 7 lesions were positive for detection; the remaining 5 lesions were still negative for US examination.
INTRODUCTION
We have previously reported effectiveness of breast cancer screening by combination usage of ultrasonography (US) and mammography (MMG). [1] In this paper, we reexamined the undetectable cases either by MMG or US to elucidate the reason of the negative findings.
MATERIALS AND METHODS
In a series of 89 cases of breast cancer detected by a combination usage of breast ultrasonography and mammography during a period of February 1995 to August 2002, 20 lesions were undetectable either by US or MMG. Age group distribution of the 89 cases were as follows; Four cases were age between 30 to 39, 47 were age 40-49, 27 were age 50-59, and 11 cases were age 60-69.
In the screening examination of our health check-up, MMG was carried out medio-lateral oblique view either by Senograph 500T or 500TS (GE-CGR) and US examination was performed either by SSD-650CL or SSD-2000 with a 10 MHz probe (Aloka) or SSA-250A with an annular array probe (Toshiba). The secondary examination was performed with reexamination of MMG and US in the out-patients specializing in breast diseases. The stages of lesions undetectable using MMG or US are displayed in Fig. 2 Table 1 . When we did a secondary examination by MMG, the number of lesions not delineated at all were 11, from case 1 to 11. The 3 lesions between case 12 and 14 were able to be detected using a technique of spot photography, but they could not be delineated by ordinal 2-direction photography. The 6 lesions between case 15 and 20 were able to detect by 2-direction photography.
RESULTS

Frequency
Reexamination of US undetectable lesion
Result of reexamination by US on the 13 US undetectable lesions, which had been shown positive by MMG, is summarized in Table 2 . Case 13 were not available for US reexamination. In case 1 to 5, lesions were not delineated even by the reexamination by US. The 5 lesions between case 6 and 10 were able to be delineated with US, but required an extended examination after imaging microcalcifications using MMG. Case 11 and 12 were invasive carcinomas detected as a mass lesion by US during a reexamination.
DISCUSSION
We have been using a combination of MMG and US in breast cancer screening since 1995. At this time, cancer detection rates by US are a bit higher than by MMG. We have reported that in human dry dock examination, where the high levels of accuracy are sought, a combined usage of MMG and US is advantageous". In this study we analyzed undetectable cancer cases using MMG or US, and investigated the limits of cancer detection ability at the time of screening examination using each examination method.
The frequency of undetectable cancer lesions using MMG and US were 22.5% and 14.6%, respectively. Many of the cases, especially those in their 40s, showed higher rates of undetection by MMG (21.3%) than with US (10.6%). In terms of stages of undetected lesions, about 80% were in early stage such as Stage 0 or Stage I. By US, non-invasive lesions in Stage 0 were half of the total of undetectable cancer lesions.
Next we examined the causes why the lesions were or were not detectable during secondary extended examinations and were not detectable at the time of the first examination. It was thought that for the 20 lesions undetected by MMG, detection by MMG would be difficult for the 11 lesions not delineated with MMG even during extended secondary examination and for the 3 lesions delineated only using spot photography. Accordingly, there were 14 lesions considered difficult to detect using MMG at the time of the screening examination. This was 15.7% of the total number of 89 cancer lesions detected. In other words, the limit of detection ability using MMG for breast cancer was about 84%. The age composition for these 14 lesions was relatively high for younger subjects: 1 case in the 30s and 8 cases in the 40s. There were also 4 lesions in Stage II of cancer. We should try to raise the accuracy of clinical breast examination in breast cancer screening by using MMG in conjunction with clinical breast examination.
We investigated 12 lesions undetectable by US, with the exception of 1 case, which was unavailable for US reexamination. The 5 lesions were still undetectable during the secondary examination and the remaining 5 lesions were, through diligent scanning with a probe, finally detected high frequency wave echoes of calcified lesions. These 10 lesions, which were detected as a microcalcification image by MMG, were cases of noninvasive ductal carcinoma or partially invasive papillotubular carcinoma. It is thought that detection was difficult at the time of the first examination by US. Consequently, 10 lesions (11.2%) of the 89 cancer lesions discovered were difficult to detect using US. The limit of detection ability by US was about 89%. In the future we must investigate accuracy standards in breast cancer examinations using US alone where cases are detected in human dry dock.
